Ana Hennino

Ana Hennino is currently the Chief Scientific Officer at Stromacare SAS since January 2022. With a background in Immunology, she completed her PhD at INSERM in Lyon in 2001. Ana has expertise in molecular mechanisms involved in apoptosis in the B cell compartment and has identified c-FLIP as a key regulator of B cell apoptosis in the germinal center. She also works as a CHARGEE DE RECHERCHE at INSERM, focusing on pancreatic ductal adenocarcinoma and the stroma/desmoplastic reaction in cancer. Ana's educational background includes a Master's degree in Immunology from École normale supérieure de Lyon and a PhD in Immunology from Université Claude Bernard Lyon 1.